Sign in
4

Changes in Ownership

FENNEC PHARMACEUTICALS INC. Filed Acc 0002043317-26-000016

Chief Commercial Officer acquired 2,326 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Evans Terry L · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-10-12 Grant or award : show line 1 in the form +2,326 $5.53 $12,863 24,013 D
Loading xslF345X06/form4-10132026_041005.xml…